Feb 6, 2023Press Release 2023Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B AntigenVirax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health...
Feb 6, 2023Press Release 2023Cosmos Health Announces Initial Purchase Order with Virax BiolabsCosmos Health announce the first purchase order to market and distribute Virax Biolabs' (Nasdaq: VRAX) ViraxClear
Feb 2, 2023Press Release 2023Cosmos Health Announces Application for Dual Listing on UpstreamCosmos Health announced that is has begun the application process to dual list its shares on Upstream, the trading app for digital securitie
Jan 31, 2023Press Release 2023Cosmos Health Announces the Appointment of Nikos Bardakis as Chief Operating OfficerCosmos Health is pleased to announce the appointment of Nikos Bardakis, who comes with over two decades experience
Jan 25, 2023Press Release 2023Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading IrregularitiesCosmos Health announces that in response to the data obtained through Shareholder Intelligence Services